Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Czech Brain Aging Study (CBAS): prospective multicentre cohort study on risk and protective factors for dementia in the Czech Republic

K. Sheardova, M. Vyhnalek, Z. Nedelska, J. Laczo, R. Andel, R. Marciniak, J. Cerman, O. Lerch, J. Hort,

. 2019 ; 9 (12) : e030379. [pub] 20191218

Jazyk angličtina Země Velká Británie

Typ dokumentu časopisecké články, multicentrická studie, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc20028704

PURPOSE: Identification of demographic, physical/physiological, lifestyle and genetic factors contributing to the onset of dementia, specifically Alzheimer disease (AD), and implementation of novel methods for early diagnosis are important to alleviate prevalence of dementia globally. The Czech Brain Aging Study (CBAS) is the first large, prospective study to address these issues in Central/Eastern Europe by enrolling non-demented adults aged 55+ years, collecting a variety of personal and biological measures and tracking cognitive function over time. PARTICIPANTS: The CBAS recruitment was initiated in 2011 from memory clinics at Brno and Prague University Hospitals, and by the end of 2018, the study included 1228 participants. Annual follow-ups include collection of socioeconomic, lifestyle and personal history information, neurology, neuropsychology, laboratory, vital sign and brain MRI data. In a subset, biomarker assessment (cerebrospinal fluid (CSF) and amyloid positron emission tomography) and spatial navigation were performed. Participants were 69.7±8.1 years old and had 14.6±3.3 years of education at baseline, and 59% were women. By the end of 2018, 31% finished three and more years of follow-up; 9% converted to dementia. Apolipoprotein E status is available from 95% of the participants. The biological sample bank linked to CBAS database contained CSF, serum and DNA. FINDINGS TO DATE: Overall, the findings, mainly from cross-sectional analyses, indicate that spatial navigation is a promising marker of early AD and that it can be distinguished from other cognitive functions. Specificity of several standard memory tests for early AD pathology was assessed with implications for clinical practice. The relationship of various lifestyle factors to cognition and brain atrophy was reported. FUTURE PLANS: Recruitment is ongoing with secured funding. Longitudinal data analyses are currently being conducted. Proposals for collaboration on specific data from the database or biospecimen, as well as collaborations with similar cohort studies to increase sample size, are welcome. Study details are available online (www.cbas.cz).

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc20028704
003      
CZ-PrNML
005      
20250709093553.0
007      
ta
008      
210105s2019 xxk f 000 0|eng||
009      
AR
024    7_
$a 10.1136/bmjopen-2019-030379 $2 doi
035    __
$a (PubMed)31857299
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxk
100    1_
$a Sheardova, Katerina $u International Clinical Research Center, St. Anne's University Hospital, Brno, Czech Republic ksheardova@gmail.com. Neurology Department, St. Anne's University Hospital, Brno, Czech Republic.
245    10
$a Czech Brain Aging Study (CBAS): prospective multicentre cohort study on risk and protective factors for dementia in the Czech Republic / $c K. Sheardova, M. Vyhnalek, Z. Nedelska, J. Laczo, R. Andel, R. Marciniak, J. Cerman, O. Lerch, J. Hort,
520    9_
$a PURPOSE: Identification of demographic, physical/physiological, lifestyle and genetic factors contributing to the onset of dementia, specifically Alzheimer disease (AD), and implementation of novel methods for early diagnosis are important to alleviate prevalence of dementia globally. The Czech Brain Aging Study (CBAS) is the first large, prospective study to address these issues in Central/Eastern Europe by enrolling non-demented adults aged 55+ years, collecting a variety of personal and biological measures and tracking cognitive function over time. PARTICIPANTS: The CBAS recruitment was initiated in 2011 from memory clinics at Brno and Prague University Hospitals, and by the end of 2018, the study included 1228 participants. Annual follow-ups include collection of socioeconomic, lifestyle and personal history information, neurology, neuropsychology, laboratory, vital sign and brain MRI data. In a subset, biomarker assessment (cerebrospinal fluid (CSF) and amyloid positron emission tomography) and spatial navigation were performed. Participants were 69.7±8.1 years old and had 14.6±3.3 years of education at baseline, and 59% were women. By the end of 2018, 31% finished three and more years of follow-up; 9% converted to dementia. Apolipoprotein E status is available from 95% of the participants. The biological sample bank linked to CBAS database contained CSF, serum and DNA. FINDINGS TO DATE: Overall, the findings, mainly from cross-sectional analyses, indicate that spatial navigation is a promising marker of early AD and that it can be distinguished from other cognitive functions. Specificity of several standard memory tests for early AD pathology was assessed with implications for clinical practice. The relationship of various lifestyle factors to cognition and brain atrophy was reported. FUTURE PLANS: Recruitment is ongoing with secured funding. Longitudinal data analyses are currently being conducted. Proposals for collaboration on specific data from the database or biospecimen, as well as collaborations with similar cohort studies to increase sample size, are welcome. Study details are available online (www.cbas.cz).
650    _2
$a senioři $7 D000368
650    _2
$a Alzheimerova nemoc $x epidemiologie $7 D000544
650    _2
$a kohortové studie $7 D015331
650    _2
$a demence $x epidemiologie $7 D003704
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a lidé $7 D006801
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a lidé středního věku $7 D008875
650    _2
$a prospektivní studie $7 D011446
650    _2
$a ochranné faktory $7 D065840
650    _2
$a hodnocení rizik $7 D018570
651    _2
$a Česká republika $x epidemiologie $7 D018153
655    _2
$a časopisecké články $7 D016428
655    _2
$a multicentrická studie $7 D016448
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Vyhnalek, Martin $u International Clinical Research Center, St. Anne's University Hospital, Brno, Czech Republic. Memory Clinic, Department of Neurology, Motol University Hospital, Prague, Czech Republic.
700    1_
$a Nedelska, Zuzana $u International Clinical Research Center, St. Anne's University Hospital, Brno, Czech Republic. Memory Clinic, Department of Neurology, Motol University Hospital, Prague, Czech Republic.
700    1_
$a Laczo, Jan $u International Clinical Research Center, St. Anne's University Hospital, Brno, Czech Republic. Memory Clinic, Department of Neurology, Motol University Hospital, Prague, Czech Republic.
700    1_
$a Andel, Ross $u International Clinical Research Center, St. Anne's University Hospital, Brno, Czech Republic. School of Aging Studies, University of South Florida, Tampa, Florida, USA.
700    1_
$a Marciniak, Rafal $u International Clinical Research Center, St. Anne's University Hospital, Brno, Czech Republic.
700    1_
$a Cerman, Jiri $u International Clinical Research Center, St. Anne's University Hospital, Brno, Czech Republic. Memory Clinic, Department of Neurology, Motol University Hospital, Prague, Czech Republic.
700    1_
$a Lerch, Ondřej $u International Clinical Research Center, St. Anne's University Hospital, Brno, Czech Republic. Memory Clinic, Department of Neurology, Motol University Hospital, Prague, Czech Republic. $7 xx0333546
700    1_
$a Hort, Jakub $u International Clinical Research Center, St. Anne's University Hospital, Brno, Czech Republic. Memory Clinic, Department of Neurology, Motol University Hospital, Prague, Czech Republic.
773    0_
$w MED00184484 $t BMJ open $x 2044-6055 $g Roč. 9, č. 12 (2019), s. e030379
856    41
$u https://pubmed.ncbi.nlm.nih.gov/31857299 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20210105 $b ABA008
991    __
$a 20250709093544 $b ABA008
999    __
$a ok $b bmc $g 1609039 $s 1119884
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2019 $b 9 $c 12 $d e030379 $e 20191218 $i 2044-6055 $m BMJ open $n BMJ Open $x MED00184484
LZP    __
$a Pubmed-20210105

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...